Your browser doesn't support javascript.
loading
Week 96 subgroup analyses of the phase 3, randomized AMBER and EMERALD trials evaluating the efficacy and safety of the once daily darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) single-tablet regimen in antiretroviral treatment (ART)-naïve and -experienced, virologically-suppressed adults living with HIV-1.
Huhn, Gregory D; Wilkin, Aimee; Mussini, Cristina; Spinner, Christoph D; Jezorwski, John; El Ghazi, Mohsine; Van Landuyt, Erika; Lathouwers, Erkki; Brown, Kimberley; Baugh, Bryan.
Affiliation
  • Huhn GD; Ruth M. Rothstein CORE Center, Chicago, IL, USA.
  • Wilkin A; Section on Infectious Diseases, Wake Forest School of Medicine, Winston-Salem, NC, USA.
  • Mussini C; Department of Infectious Diseases, University of Modena and Reggio Emilia, Modena, Italy.
  • Spinner CD; School of Medicine, Technical University of Munich, Munich, Germany.
  • Jezorwski J; Janssen Research and Development LLC, Pennington, NJ, USA.
  • El Ghazi M; Janssen Pharmaceutica NV, Beerse, Belgium.
  • Van Landuyt E; Janssen Pharmaceutica NV, Beerse, Belgium.
  • Lathouwers E; Janssen Pharmaceutica NV, Beerse, Belgium.
  • Brown K; Janssen Pharmaceutica NV, Beerse, Belgium.
  • Baugh B; Janssen Research and Development LLC, Raritan, NJ, USA.
HIV Res Clin Pract ; 21(6): 151-167, 2020 12.
Article in En | MEDLINE | ID: mdl-33528318

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / HIV-1 / Anti-HIV Agents Type of study: Clinical_trials Limits: Adult / Humans / Middle aged Language: En Journal: HIV Res Clin Pract Year: 2020 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / HIV-1 / Anti-HIV Agents Type of study: Clinical_trials Limits: Adult / Humans / Middle aged Language: En Journal: HIV Res Clin Pract Year: 2020 Document type: Article Affiliation country: Country of publication: